FR2396078A1 - Procede de production de substances inhibant la b lactamase et plus specialement de la mc 696 sy-2a - Google Patents

Procede de production de substances inhibant la b lactamase et plus specialement de la mc 696 sy-2a

Info

Publication number
FR2396078A1
FR2396078A1 FR7820095A FR7820095A FR2396078A1 FR 2396078 A1 FR2396078 A1 FR 2396078A1 FR 7820095 A FR7820095 A FR 7820095A FR 7820095 A FR7820095 A FR 7820095A FR 2396078 A1 FR2396078 A1 FR 2396078A1
Authority
FR
France
Prior art keywords
soln
salt
contg
beta
lactamase inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7820095A
Other languages
English (en)
Other versions
FR2396078B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Publication of FR2396078A1 publication Critical patent/FR2396078A1/fr
Application granted granted Critical
Publication of FR2396078B1 publication Critical patent/FR2396078B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99—Enzyme inactivation by chemical treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ce procédé de production consiste à cultiver une souche MC 696 SY 2 Streptomyces fulvoridis (identifié comme FERM-P 1504 on ATCC 21954), afin de produire et d'accumuler la substance MC 696 - SY 2A dans le milieu de culture puis à récupérer cette substance du bouillon de culture contenant la substance MC 696 - SY 2A, alors que cette substance est maintenue sous forme de sel de la substance MC 696 - SY 2A, après avoir converti, dans une phase appropriée antérieure du processus de récupération et de purification ladite substance en son sel.
FR7820095A 1977-06-29 1978-06-27 Procede de production de substances inhibant la b lactamase et plus specialement de la mc 696 sy-2a Granted FR2396078A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7655777A JPS5414594A (en) 1977-06-29 1977-06-29 Preparation of beta-lactamase inhibiting substance

Publications (2)

Publication Number Publication Date
FR2396078A1 true FR2396078A1 (fr) 1979-01-26
FR2396078B1 FR2396078B1 (fr) 1980-11-14

Family

ID=13608545

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7820095A Granted FR2396078A1 (fr) 1977-06-29 1978-06-27 Procede de production de substances inhibant la b lactamase et plus specialement de la mc 696 sy-2a

Country Status (4)

Country Link
JP (1) JPS5414594A (fr)
ES (1) ES471250A1 (fr)
FR (1) FR2396078A1 (fr)
IT (1) IT1103066B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008885A1 (fr) * 1978-09-09 1980-03-19 Beecham Group Plc Composés de bêta-lactame, leur préparation et application

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988570A (en) * 1985-09-11 1991-01-29 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for forming a film

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2106582A1 (fr) * 1970-09-17 1972-05-05 Beecham Group Ltd
FR2265398A1 (fr) * 1974-03-28 1975-10-24 Beecham Group Ltd

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2106582A1 (fr) * 1970-09-17 1972-05-05 Beecham Group Ltd
FR2265398A1 (fr) * 1974-03-28 1975-10-24 Beecham Group Ltd

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV2321/77 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008885A1 (fr) * 1978-09-09 1980-03-19 Beecham Group Plc Composés de bêta-lactame, leur préparation et application

Also Published As

Publication number Publication date
FR2396078B1 (fr) 1980-11-14
ES471250A1 (es) 1979-10-01
JPS5414594A (en) 1979-02-02
IT1103066B (it) 1985-10-14
IT7809512A0 (it) 1978-06-28

Similar Documents

Publication Publication Date Title
JPS55162791A (en) Antibiotic c-15003pnd and its preparation
NZ335392A (en) Method for the recombinant production of 1,3-propanediol
CA2083041A1 (fr) Composes marques utilises pour un test respiratoire diagnostique
HUT43636A (en) Process for producing 2-keto-l-gulonic acid
FR2396078A1 (fr) Procede de production de substances inhibant la b lactamase et plus specialement de la mc 696 sy-2a
EP0228274A3 (en) Method for producing 2-keto-d-glucaric-acid
ES261748A1 (es) Procedimiento para el cultivo de un organismo productor de actinoespectacina
GB857439A (en) Improvements in ground-engaging means for vehicles
MX174307B (es) Proceso para producir aminoacidos
GB979141A (en) A method for manufacturing inosinic acid by fermentation
Espelie et al. Selectively blocked derivatives of muco-inositol and their conversion into derivatives of epi-and cis-inositol
US4290972A (en) Process for the production of 4-aminobutyric acid or its derivatives
JPS55108294A (en) Production of purine nucleoside through fermentation process
JPS5420190A (en) Preparation of bacterial cells
Rhuland et al. THE BIOSYNTHESIS OF α,[UNK]-DIAMINOPIMELIC ACID. I. ISOLATION OF AN INTERMEDIATE, ACTIVE FOR A DIAMINOPIMELIC ACID-REQUIRING E. cOLI MUTANT
GB1394849A (en) 5-dihydrocoriolin c and process for producing the same
DE3060845D1 (en) Process for the preparation of penicillin derivatives
JPS5750992A (en) Antibiotic tm-531b
EP0219654A3 (en) Process for the preparation of 4-chlorbutanals
JPS6419087A (en) Production of 1,3,4-tri-o-acyl-2-deoxy-beta-d-erythro-pentapyranose
ES419202A1 (es) Procedimiento para la preparacion de alfa-lactonas de aci- dos beta-(3-ceto-7 alfa-tioacil-).
GB1244041A (en) Improved process for the production of an antibiotic substance 2'-amino-2'-deoxy-kanamycin
JPS56124384A (en) Preparative method of 2-hydroxy-6-oxo-2,4-hexadienoic acid hydrolyase
KR900001717A (ko) 호모노지리마이신 유도체의 제조방법
ES485962A1 (es) Un procedimiento para la produccion de sustancia fr-900156

Legal Events

Date Code Title Description
ST Notification of lapse